Inovio Pharmaceuticals ROCE 2024

Inovio Pharmaceuticals Aktienanalyse

What does Inovio Pharmaceuticals do?

Inovio Pharmaceuticals Inc. is a US biotechnology and pharmaceutical company specializing in the development of DNA vaccines and immunotherapies. It was founded in 1979 by Dr. Joseph Kim and is headquartered in Plymouth Meeting, Pennsylvania. Inovio began working on DNA-based vaccines in the late 1990s and developed the Electroporation technology, which facilitates the introduction of DNA molecules into cells. The company has expanded its capabilities over the years and is able to generate immune responses against a variety of viruses and bacteria. They have also made advancements in using their technology to combat cancer. Inovio's business model is based on licensing technologies and collaborating with partners such as pharmaceutical companies, government agencies, and academic institutions. They also offer services for the development and production of DNA-based vaccines for academic and industrial customers. Inovio is divided into different divisions, including DNA vaccines for infectious diseases and oncology, platform technology, and cancer immunotherapy. They offer a wide range of DNA vaccines for infectious diseases such as HPV, HIV, hepatitis B and C, as well as Lassa fever and Ebola. Inovio has also made significant progress in the development of DNA-based immunotherapies for cancer, using Electroporation technology to train and activate T-cells against cancer cells. In terms of products, Inovio has various products in different stages of clinical development, but they have not yet received FDA approval for any of their products. However, they have successfully conducted clinical trials for vaccines such as HPV, which has shown 90% efficacy against the virus. In conclusion, Inovio is a specialized company in the development of DNA-based vaccines and immunotherapy for cancer. Their Electroporation technology has led to significant breakthroughs, and they continue to pursue partnerships and further development. With their focus on research and development and advancing their technologies, it seems that Inovio is on a path of continued success. Inovio Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Inovio Pharmaceuticals's Return on Capital Employed (ROCE)

Inovio Pharmaceuticals's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Inovio Pharmaceuticals's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Inovio Pharmaceuticals's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Inovio Pharmaceuticals’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Inovio Pharmaceuticals stock

What is the ROCE (Return on Capital Employed) of Inovio Pharmaceuticals this year?

The ROCE of Inovio Pharmaceuticals is -1.14 undefined this year.

How has the ROCE (Return on Capital Employed) of Inovio Pharmaceuticals developed compared to the previous year?

The ROCE of Inovio Pharmaceuticals has increased by -5.51% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Inovio Pharmaceuticals?

A high Return on Capital Employed (ROCE) indicates that Inovio Pharmaceuticals has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Inovio Pharmaceuticals?

A low ROCE (Return on Capital Employed) can indicate that Inovio Pharmaceuticals has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Inovio Pharmaceuticals impact the company?

An increase in the ROCE of Inovio Pharmaceuticals can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Inovio Pharmaceuticals affect the company?

A decrease in ROCE of Inovio Pharmaceuticals can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Inovio Pharmaceuticals?

Some factors that can affect Inovio Pharmaceuticals's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Inovio Pharmaceuticals so important for investors?

The ROCE of Inovio Pharmaceuticals is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Inovio Pharmaceuticals take to improve the ROCE?

To improve the ROCE, Inovio Pharmaceuticals can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Inovio Pharmaceuticals pay?

Over the past 12 months, Inovio Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inovio Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Inovio Pharmaceuticals?

The current dividend yield of Inovio Pharmaceuticals is .

When does Inovio Pharmaceuticals pay dividends?

Inovio Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Inovio Pharmaceuticals?

Inovio Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Inovio Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Inovio Pharmaceuticals located?

Inovio Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Inovio Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Inovio Pharmaceuticals from 9/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.

When did Inovio Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/30/2024.

What was the dividend of Inovio Pharmaceuticals in the year 2023?

In the year 2023, Inovio Pharmaceuticals distributed 0 USD as dividends.

In which currency does Inovio Pharmaceuticals pay out the dividend?

The dividends of Inovio Pharmaceuticals are distributed in USD.